CA1253807A - Compose topique pour la protection et le traitement de la peau et des cheveux humains - Google Patents

Compose topique pour la protection et le traitement de la peau et des cheveux humains

Info

Publication number: CA1253807A
Authority: CA; Canada
Prior art keywords: agents; weight; topical composition; composition according; additive
Prior art date: 1985-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000491517A

Other languages

English (en)

Inventor

Jacques Valentine

Michel Cote

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-25

Filing date

1985-09-25

Publication date

1989-05-09

1985-09-25 Application filed by Individual filed Critical Individual

1985-09-25 Priority to CA000491517A priority Critical patent/CA1253807A/fr

1989-05-09 Application granted granted Critical

1989-05-09 Publication of CA1253807A publication Critical patent/CA1253807A/fr

Status Expired legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 70
230000000699 topical effect Effects 0.000 title claims abstract description 20
238000011282 treatment Methods 0.000 title claims abstract description 7
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 17
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
239000000654 additive Substances 0.000 claims abstract description 15
239000004166 Lanolin Substances 0.000 claims abstract description 14
229940039717 lanolin Drugs 0.000 claims abstract description 14
235000019388 lanolin Nutrition 0.000 claims abstract description 14
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 13
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 13
229940031439 squalene Drugs 0.000 claims abstract description 13
150000003626 triacylglycerols Chemical class 0.000 claims abstract description 11
239000002480 mineral oil Substances 0.000 claims abstract description 8
235000010446 mineral oil Nutrition 0.000 claims abstract description 8
125000002252 acyl group Chemical group 0.000 claims abstract description 6
239000003795 chemical substances by application Substances 0.000 claims description 21
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
QELSKZZBTMNZEB-UHFFFAOYSA-N p-hydroxybenzoic acid propyl ester Natural products CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 14
239000013543 active substance Substances 0.000 claims description 13
239000003921 oil Substances 0.000 claims description 10
239000006071 cream Substances 0.000 claims description 8
235000012000 cholesterol Nutrition 0.000 claims description 7
BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 7
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 7
239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 7
229960003415 propylparaben Drugs 0.000 claims description 7
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
239000003974 emollient agent Substances 0.000 claims description 6
239000003755 preservative agent Substances 0.000 claims description 6
JYGXADMDTFJGBT-VWUMJDOOSA-N Hydrocortisone Natural products O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 5
239000003995 emulsifying agent Substances 0.000 claims description 5
239000002304 perfume Substances 0.000 claims description 5
229940121375 antifungal agent Drugs 0.000 claims description 4
BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical group CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims description 4
230000003115 biocidal effect Effects 0.000 claims description 4
229960000541 cetyl alcohol Drugs 0.000 claims description 4
LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 4
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
239000003381 stabilizer Substances 0.000 claims description 4
239000000126 substance Substances 0.000 claims description 4
239000003429 antifungal agent Substances 0.000 claims description 3
239000004599 antimicrobial Substances 0.000 claims description 3
238000004040 coloring Methods 0.000 claims description 3
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
235000011187 glycerol Nutrition 0.000 claims description 3
229960000890 hydrocortisone Drugs 0.000 claims description 3
239000003410 keratolytic agent Substances 0.000 claims description 3
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
239000000546 pharmaceutical excipient Substances 0.000 claims description 3
239000000516 sunscreening agent Substances 0.000 claims description 3
239000002562 thickening agent Substances 0.000 claims description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
229960005274 benzocaine Drugs 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 2
229960002216 methylparaben Drugs 0.000 claims description 2
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
229960004889 salicylic acid Drugs 0.000 claims description 2
230000000996 additive effect Effects 0.000 claims 9
239000003470 adrenal cortex hormone Substances 0.000 claims 2
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical group NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims 2
239000003963 antioxidant agent Substances 0.000 claims 2
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims 1
229960000458 allantoin Drugs 0.000 claims 1
125000000017 cortisol group Chemical group 0.000 claims 1
239000008387 emulsifying waxe Substances 0.000 claims 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
230000003020 moisturizing effect Effects 0.000 abstract description 6
208000003251 Pruritus Diseases 0.000 abstract description 5
201000004624 Dermatitis Diseases 0.000 abstract description 4
206010012438 Dermatitis atopic Diseases 0.000 abstract description 4
201000008937 atopic dermatitis Diseases 0.000 abstract description 4
208000005373 Dyshidrotic Eczema Diseases 0.000 abstract description 3
206010015150 Erythema Diseases 0.000 abstract description 3
201000004681 Psoriasis Diseases 0.000 abstract description 3
206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract description 3
208000010668 atopic eczema Diseases 0.000 abstract description 3
208000013046 dyshidrosis Diseases 0.000 abstract description 3
231100000321 erythema Toxicity 0.000 abstract description 3
201000011414 pompholyx Diseases 0.000 abstract description 3
208000008742 seborrheic dermatitis Diseases 0.000 abstract description 3
239000002904 solvent Substances 0.000 abstract description 3
206010012442 Dermatitis contact Diseases 0.000 abstract description 2
206010013786 Dry skin Diseases 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
230000037336 dry skin Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 description 5
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
229940097789 heavy mineral oil Drugs 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
210000000464 vernix caseosa Anatomy 0.000 description 3
239000001993 wax Substances 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 2
229940074928 isopropyl myristate Drugs 0.000 description 2
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
-1 polyoxyethylene lauryl ether Polymers 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
102000001324 CD59 Antigens Human genes 0.000 description 1
108010055167 CD59 Antigens Proteins 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
229940124091 Keratolytic Drugs 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
QSDSSSQWVNLFIG-UHFFFAOYSA-N Neosporin Natural products CC(O)CC1=C(OC)C(=O)C2=CC(O)=C3OCOC4=C(O)C=C5C6=C4C3=C2C1=C6C(CC(C)O)=C(OC)C5=O QSDSSSQWVNLFIG-UHFFFAOYSA-N 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
241000223238 Trichophyton Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
230000001153 anti-wrinkle effect Effects 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
229910021538 borax Inorganic materials 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
229930003836 cresol Natural products 0.000 description 1
229940013361 cresol Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
108010046161 drug combination polymyxin B neomycin sulfate bacitracin zinc Proteins 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
210000001061 forehead Anatomy 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
239000003676 hair preparation Substances 0.000 description 1
230000035876 healing Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000001530 keratinolytic effect Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
229960002900 methylcellulose Drugs 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
229940105132 myristate Drugs 0.000 description 1
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
229940049337 neosporin Drugs 0.000 description 1
125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
YAGMLECKUBJRNO-UHFFFAOYSA-N octyl 4-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(N(C)C)C=C1 YAGMLECKUBJRNO-UHFFFAOYSA-N 0.000 description 1
239000002674 ointment Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
229940093625 propylene glycol monostearate Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
229960004599 sodium borate Drugs 0.000 description 1
235000010339 sodium tetraborate Nutrition 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
239000012177 spermaceti Substances 0.000 description 1
229940084106 spermaceti Drugs 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
229940012831 stearyl alcohol Drugs 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003756 stirring Methods 0.000 description 1
TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Birds (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Emergency Medicine (AREA)
Zoology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)

CA000491517A 1985-09-25 1985-09-25 Compose topique pour la protection et le traitement de la peau et des cheveux humains Expired CA1253807A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000491517A CA1253807A (fr)	1985-09-25	1985-09-25	Compose topique pour la protection et le traitement de la peau et des cheveux humains

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000491517A CA1253807A (fr)	1985-09-25	1985-09-25	Compose topique pour la protection et le traitement de la peau et des cheveux humains

Publications (1)

Publication Number	Publication Date
CA1253807A true CA1253807A (fr)	1989-05-09

Family

ID=4131468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000491517A Expired CA1253807A (fr)	1985-09-25	1985-09-25	Compose topique pour la protection et le traitement de la peau et des cheveux humains

Country Status (1)

Country	Link
CA (1)	CA1253807A (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991007167A1 (fr) *	1989-11-09	1991-05-30	Schering-Plough Healthcare Products, Inc.	Activateurs de la kinase de proteine comme promoteurs de la production de melamine
EP0467218A3 (en) *	1990-07-17	1993-03-03	Beiersdorf Aktiengesellschaft	Combinations of active agents for skin care
WO1993007847A1 (fr) *	1991-10-15	1993-04-29	Kenneth Vincent Mason	Composition antiseborrheique
FR2693370A1 (fr) *	1992-07-08	1994-01-14	Melin Gisele	Baume à base de suif et de salicylate de méthyle destiné en particulier au traitement du cuir chevelu.
EP0775486A1 (fr) *	1995-11-23	1997-05-28	Beiersdorf Aktiengesellschaft	Compositions anti-bactériennes, anti-mycotiques et anti-virales, basées sur des acides alpha-hydroxyalcanoiques et du squalène
FR2885491A1 (fr) *	2005-05-16	2006-11-17	Inneov Lab	Traitement de la secheresse keratinique par des glycerides

1985
- 1985-09-25 CA CA000491517A patent/CA1253807A/fr not_active Expired

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991007167A1 (fr) *	1989-11-09	1991-05-30	Schering-Plough Healthcare Products, Inc.	Activateurs de la kinase de proteine comme promoteurs de la production de melamine
EP0467218A3 (en) *	1990-07-17	1993-03-03	Beiersdorf Aktiengesellschaft	Combinations of active agents for skin care
WO1993007847A1 (fr) *	1991-10-15	1993-04-29	Kenneth Vincent Mason	Composition antiseborrheique
AU666139B2 (en) *	1991-10-15	1996-02-01	Kenneth Vincent Mason	Anti-seborrhoeic formulation
FR2693370A1 (fr) *	1992-07-08	1994-01-14	Melin Gisele	Baume à base de suif et de salicylate de méthyle destiné en particulier au traitement du cuir chevelu.
EP0775486A1 (fr) *	1995-11-23	1997-05-28	Beiersdorf Aktiengesellschaft	Compositions anti-bactériennes, anti-mycotiques et anti-virales, basées sur des acides alpha-hydroxyalcanoiques et du squalène
FR2885491A1 (fr) *	2005-05-16	2006-11-17	Inneov Lab	Traitement de la secheresse keratinique par des glycerides
WO2007000529A3 (fr) *	2005-05-16	2007-07-12	Inneov Lab	Traitement de la secheresse keratinique par des glycerides
JP2008540621A (ja) *	2005-05-16	2008-11-20	ラボラトワールイネオフ	グリセリド類を用いる角質性乾燥の処置

Legal Events

Date	Code	Title	Description
2006-05-09	MKEX	Expiry

Publication	Publication Date	Title
KR890002021B1 (ko)	1989-06-08	보습 로숀
CA2168495C (fr)	2006-12-12	Composition lipidique pour produits cosmetiques
JP4421801B2 (ja)	2010-02-24	補酵素ｑを有効成分とする皮膚用組成物
JPS60142920A (ja)	1985-07-29	抗▲ざ▼瘡剤
JPWO1997002803A1 (ja)	1997-10-28	皮膚外用剤
JPH04234306A (ja)	1992-08-24	皮膚保護作用化合物配合物
JP2552297B2 (ja)	1996-11-06	美肌化粧料
US5804574A (en)	1998-09-08	Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
JPH0262818A (ja)	1990-03-02	養毛組成物
CA1142854A (fr)	1983-03-15	Methode et compose pour le traitement de la seborrhee
US3876765A (en)	1975-04-08	Pharmaceutical composition containing vitamin b' 12', process of making the same and method of treatment therewith
JP2720246B2 (ja)	1998-03-04	皮膚外用剤
JP2663136B2 (ja)	1997-10-15	美白化粧料
JP2552298B2 (ja)	1996-11-06	美肌化粧料
JPH0296581A (ja)	1990-04-09	ビオチンエステル及びそれを用いた皮膚外用剤、養毛料
JP3441387B2 (ja)	2003-09-02	保湿剤及び皮膚化粧料並びに入浴剤
JPH10158142A (ja)	1998-06-16	光老化防止改善剤および皮膚外用剤
JP2785035B2 (ja)	1998-08-13	化粧料および外用剤
JPS6219513A (ja)	1987-01-28	養毛剤
JPH0632710A (ja)	1994-02-08	皮膚外用剤
JPH0517317A (ja)	1993-01-26	化粧料及び外用剤
JP2522803B2 (ja)	1996-08-07	化粧料
JPH0692833A (ja)	1994-04-05	皮膚外用剤
JPH06316553A (ja)	1994-11-15	アルカノールアミンの用途
KR20160014271A (ko)	2016-02-11	히드로퀴논을 포함하는 저자극성 피부 미백용 조성물